1802580 PAGE – Peritoneal diAlysis and Glucose Exposure V1.2 Glycaemic Variability in Peritoneal Dialysis 31/08/2018
1710511 PAVE Paclitaxel assisted balloon Angioplasty of Venous stenosis in haEmodialysis access: The PAVE trial. A multicentre double-blind randomised controlled trial in haemodialysis patients with a stenosis in a native arteriovenous fistula. 30/09/2018
1304763 PD-CRAFT A study of Clinical and Genetic Risk Factors for Encapsulating Peritoneal Sclerosis 30/11/2018
1706453 BioImpedance Spectroscopy to Maintain Renal Output: The BISTRO Trial BioImpedance Spectroscopy to Maintain Renal Output: The BISTRO Trial 30/12/2018
1610316 RENA4131 A Phase 3b, Multi-center, Open-label Trial to Evaluate the Long Term Safety of a Titrated Immediate-release selective arginine vasopressin type 2 receptor antagonist (30 mg to 120 mg/day, Split dose) in Subjects with Autosomal Dominant Polycystic Kidney Disease (protocol 156-13-211) 31/12/2018
1710508 CL010_168 A Randomized, double-blind, placebo-controlled, phase 3 study to evaluate the safety and efficacy of CCX168 in patients with anti-neutrophil cytoplasmic antibody (ANCA)- Associated Vasculitis Treated Concomitantly with Rituximab or Cyclophosphamise/ Azathioprine 31/12/2018
1706439 Microcirculatory function in peritoneal dialysis Microcirculatory function in peritoneal dialysis 08/02/2019
1506108 RADAR National Studies of Rare Kidney Diseases 31/03/2019
1115498 NephroS: The National Study of Nephrotic Syndrome (NURTuRE) A study to correlate the epidemiological and clinical features of Steroid Resistance Nephrotic Syndrome including FSGS (Focal Segmental GlomeruloSclerosis) in childhood, in the UK, with genotype and to develop biomarkers of disease activity post transplantation 31/12/2019
1502050 UKIVAS Development of a Pan UK Vasculitis Cohort to Analyse Variations in Disease Susceptibility and Outcomes 31/12/2019
1712549 A 6-year, Multicentre, Non-interventional, Post-authorisation Safety Study for Patients Prescribed JINARC® for Autosomal Dominant Polycystic Kidney Disease A 6-year, Multicentre, Non-interventional, Post-authorisation Safety Study for Patients Prescribed JINARC® for Autosomal Dominant Polycystic Kidney Disease 31/12/2019
1804578 Natural History Study of C3 Glomerulopathy Natural History Study of C3 Glomerulopathy: Discovery of Histological Predictors of Outcome 31/12/2019
1706448 AQ-03 SINGLE ARM, STUDY OF ALXN1210 IN COMPLEMENT INHIBITOR TREATMENT-NAÏVE ADULT AND ADOLESCENT PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) 13/02/2020
1803564 Cholecalciferol in Patients on Dialysis – SIMPLIFIED Survival Improvement with Cholecalciferol in Patients on Dialysis – The SIMPLIFIED Registry Trial 31/03/2020